Larimar Therapeutics (LRMR)
(Delayed Data from NSDQ)
$3.77 USD
+0.03 (0.80%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.78 +0.01 (0.27%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Larimar Therapeutics, Inc. has a market cap of $239.46M, which represents its share price of $3.74 multiplied by its outstanding shares number of 64.03M. As a small-cap company, LRMR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LRMR 3.77 +0.03(0.80%)
Will LRMR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LRMR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LRMR
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
LRMR: What are Zacks experts saying now?
Zacks Private Portfolio Services
SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
5 Small Drug Stocks to Buy as Trump Gets Re-Elected
Other News for LRMR
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and ...
LRMR Stock Priced at Lower End of Predetermined Range
Larimar Therapeutics 18.75M share Spot Secondary priced at $3.20
Larimar Therapeutics Announces Pricing of Underwritten Public Offering | LRMR Stock News
Larimar Therapeutics prices $60M stock offering